The FTSE 100 opened higher on 16 September 2026, climbing 0.38 per cent to 10,697.83 as investors awaited the Federal Reserve’s interest-rate decision. European markets followed suit, with the Euronext 100 rising
Aldi chief executive Giles Hurley has entered the heated debate over supermarket profiteering, throwing his weight behind government efforts to tackle misleading promotions. Hurley said the government is “right” to take on
More
Employers cannot simply place a disabled employee on unpaid leave and consider their obligations under the Americans with Disabilities Act fulfilled, the Fourth Circuit Court of Appeals has ruled. The court reversed
More
Today’s legal headlines span federal courts, high-profile criminal cases, and a striking new twist on artificial intelligence in the courtroom. A judge has threatened the Department of Justice with contempt in connection
More
The UK stock market has long been dismissed by global investors, but evidence continues to mount that it deserves far greater attention than it currently receives. For years, the London market has
More
The Sporting Events Bill, introduced in the House of Lords on 14 May 2026, is set to reshape how brands and media owners operate around major sporting events in the UK. Rather
More
Burnley Football Club has terminated its front-of-shirt sponsorship deal with trading platform Finotive just six weeks after the agreement was announced in early July. The club confirmed the decision on Friday morning,
More
Wayfair LLC is facing continued legal exposure in California after a federal court allowed key privacy claims against the online home goods retailer to move forward. The United States District Court for
More
Despite a prolonged period of underperformance, Burberry Group (LSE: BRBY) is showing genuine signs of recovery that investors may be too quick to dismiss. The luxury fashion house has seen its shares
More
Zeekr is bringing its largest and most powerful SUV to Europe, and the 9X Super Hybrid is not making a quiet entrance by any measure. The Chinese luxury SUV packs a claimed
More
Fresenius Kabi has pulled a single batch of its biosimilar Tyenne (tocilizumab-aazg) injection in 20 ml vials following the discovery of glass particles in the product. The German-headquartered drugmaker confirmed the recall
More